The May N2 Stakeholder meeting is on Monday, May 17, 2021, from 2:00-3:00 PM EST. For this session, N2 will provide membership and committee updates and include a feature presentation from Pat Clifford about CTO's Re-Imagine working group initiatives. REGISTER HERE...
The Population Genomics Program at McMaster University is thrilled to announce their third ‘OMICS and Epidemiology Conference, being held virtually on May 27 – 28, 2021. The conference will explore the evidence for ‘omics and utility in the health care setting –...
N2 is looking to assess its current Human Resources (HR) policies and practices to ensure it is up to date with best and commonly accepted industry standards. In addition, it is looking for a review of staffing and advice on benchmarking on compensation for existing...
Enhancing Canada’s Research Capability & Capacity
years of service
Our membership has allowed us to learn from successes in other provinces, implement new ideas, keep abreast of new developments in the Canadian clinical trials landscape, and network with other clinical research groups faced with similar challenges and opportunities.
It is well worth attending the two-day Annual General Meetings and with each successive AGM, you can see and hear how N2 is growing by leaps and bounds and likewise the enthusiasm and volunteerism exhibited at the meetings, all of which makes for relevant and informative discussions.
Through their outreach to various stakeholders, N2 partnership definitely gives Canada an edge and helps us, the pharmaceutical industry, to continue to attract and leverage the implementation of clinical trials in Canada; ensuring a high level of quality and compliance.
Being a member of N2 has provided us with the opportunity to develop collaborative working relationships with clinical research organizations across Canada. These networking opportunities have helped us to streamline processes, share and create resources, and learn from other clinical research experts’ experiences.